Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $34,968 - $39,887
-94 Reduced 2.37%
3,873 $1.6 Million
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $809,030 - $1.17 Million
2,840 Added 252.0%
3,967 $1.6 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $256,415 - $352,390
1,127 New
1,127 $345,000
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $333,106 - $457,722
1,911 New
1,911 $359,000
Q1 2022

May 16, 2022

SELL
$138.87 - $214.31 $396,890 - $612,497
-2,858 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $317,053 - $395,406
1,735 Added 154.5%
2,858 $622,000
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $285,562 - $332,596
-1,678 Reduced 59.91%
1,123 $213,000
Q2 2021

Aug 16, 2021

BUY
$158.62 - $194.3 $178,923 - $219,170
1,128 Added 67.42%
2,801 $495,000
Q1 2021

May 17, 2021

BUY
$132.02 - $168.26 $220,869 - $281,498
1,673 New
1,673 $274,000
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $565,603 - $771,461
-5,171 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$92.95 - $130.61 $134,498 - $188,992
-1,447 Reduced 21.86%
5,171 $578,000
Q2 2020

Aug 14, 2020

BUY
$68.08 - $95.68 $450,553 - $633,210
6,618 New
6,618 $616,000
Q2 2019

Aug 14, 2019

SELL
$53.64 - $65.42 $252,858 - $308,389
-4,714 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$49.38 - $70.58 $232,777 - $332,714
4,714 New
4,714 $278,000
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $521,977 - $711,009
-11,113 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $267,371 - $394,040
6,182 Added 125.37%
11,113 $666,000
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $167,801 - $224,163
4,931 New
4,931 $212,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.